Sulindac sulfone (FGN-1) in patients with familial adenomatous polyposis (FAP): Polyp effect and tolerability from an open label extension trial

Authors :: James M. Church
Rifat Pamukcu
Carol A. Burke
K. Provencher
R. U. Van Stolk
Source :: Gastroenterology. 114:A697
Publication Year :: 1998
Publisher :: Elsevier BV, 1998.

Subjects :: medicine.medical_specialty
Hepatology
business.industry
Gastroenterology
medicine.disease
Sulindac sulfone
Familial adenomatous polyposis
Tolerability
Internal medicine
Medicine
In patient
Open label
business

Tools